{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T15:26:46Z","timestamp":1791559606229,"version":"4.3.4"},"reference-count":25,"publisher":"MDPI AG","issue":"14","license":[{"start":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T00:00:00Z","timestamp":1753056000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["20-75-10033-P."],"award-info":[{"award-number":["20-75-10033-P."]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background\/Objectives: In gastric cancer, only a subset of patients benefit clinically from neoadjuvant chemoimmunotherapy, underscoring the need for robust biomarkers that can predict treatment responses and guide personalized immunotherapy. This study aimed to characterize the immune microenvironment of gastric tumors and identify predictive markers associated with therapeutic efficacy. Methods: We prospectively enrolled 16 patients with histologically confirmed, PD-L1\u2013positive (CPS \u2265 1) gastric adenocarcinoma (T2\u20134N0\u20131M0). All patients received eight cycles of FLOT chemotherapy combined with pembrolizumab. Treatment response was assessed by Mandard tumor regression grading. Spatial transcriptomic profiling (10x Genomics Visium) and multiplex immunofluorescence were used to evaluate tumor-infiltrating immune cell subsets and PD-1 expression at baseline and after treatment. Results: Transcriptomic analysis differentiated the immune landscapes of responders from non-responders. Responders exhibited elevated expression of IL1B, CXCL5, HMGB1, and IFNGR2, indicative of an inflamed tumor microenvironment and type I\/II interferon signaling. In contrast, non-responders demonstrated upregulation of immunosuppressive genes such as LGALS3, IDO1, and CD55, along with enrichment in oxidative phosphorylation and antigen presentation pathways. Multiplex immunofluorescence confirmed a higher density of FoxP3+ regulatory T cells in non-responders (median 5.36% vs. 2.41%; p = 0.0032). Notably, PD-1+ CD8+ T cell and PD-1+ FoxP3+ Treg frequencies were significantly elevated in non-responders, suggesting that PD-1 expression within cytotoxic and regulatory compartments may contribute to immune evasion. No substantial differences were observed in PD-L1 CPS or PD-1+ B cells and PD-1+ macrophages. Conclusions: Our findings identify PD-1+ CD8+ T cells and PD-1+ FoxP3+ Tregs as potential biomarkers of resistance to neoadjuvant chemoimmunotherapy in gastric cancer. Transcriptional programs centered on IL1B\/CXCL5 and LGALS3\/IDO1 define distinct immune phenotypes that may guide future combination strategies targeting both effector and suppressive arms of the tumor immune response.<\/jats:p>","DOI":"10.3390\/cancers17142407","type":"journal-article","created":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T11:44:05Z","timestamp":1753098245000},"page":"2407","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["PD-1-Positive CD8+ T Cells and PD-1-Positive FoxP3+ Cells in Tumor Microenvironment Predict Response to Neoadjuvant Chemoimmunotherapy in Gastric Cancer Patients"],"prefix":"10.3390","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2061-8417","authenticated-orcid":false,"given":"Liubov A.","family":"Tashireva","sequence":"first","affiliation":[{"name":"The Laboratory of Molecular Therapy of Cancer, Cancer Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk 634050, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2106-3513","authenticated-orcid":false,"given":"Anna Yu.","family":"Kalinchuk","sequence":"additional","affiliation":[{"name":"The Laboratory of Molecular Therapy of Cancer, Cancer Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk 634050, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6637-4417","authenticated-orcid":false,"given":"Elena O.","family":"Shmakova","sequence":"additional","affiliation":[{"name":"The Laboratory of Molecular Therapy of Cancer, Cancer Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk 634050, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisaveta A.","family":"Tsarenkova","sequence":"additional","affiliation":[{"name":"The Laboratory of Molecular Therapy of Cancer, Cancer Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk 634050, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmitriy M.","family":"Loos","sequence":"additional","affiliation":[{"name":"The Department of General and Molecular Pathology, Cancer Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk 634050, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavel","family":"Iamschikov","sequence":"additional","affiliation":[{"name":"Center for Systems Bioinformatics, Tomsk National Research Medical Center, Tomsk 634050, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-4437-6583","authenticated-orcid":false,"given":"Ivan A.","family":"Patskan","sequence":"additional","affiliation":[{"name":"The Laboratory of Molecular Therapy of Cancer, Cancer Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk 634050, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra V.","family":"Avgustinovich","sequence":"additional","affiliation":[{"name":"The Department of Abdominal Oncology, Cancer Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk 634050, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1195-4008","authenticated-orcid":false,"given":"Sergey V.","family":"Vtorushin","sequence":"additional","affiliation":[{"name":"The Department of General and Molecular Pathology, Cancer Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk 634050, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina V.","family":"Larionova","sequence":"additional","affiliation":[{"name":"The Laboratory of Molecular Therapy of Cancer, Cancer Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk 634050, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evgeniya S.","family":"Grigorieva","sequence":"additional","affiliation":[{"name":"The Laboratory of Molecular Therapy of Cancer, Cancer Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk 634050, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,7,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Wang, J., Tong, T., Zhang, G., Jin, C., Guo, H., Liu, X., Zhang, Z., Li, J., and Zhao, Y. (2024). Evaluation of neoadjuvant immunotherapy in resectable gastric\/gastroesophageal junction tumors: A meta-analysis and systematic review. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1339757"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1084\/jem.20180684","article-title":"High-dimensional single cell analysis identifies stem-like cytotoxic CD8+ T cells infiltrating human tumors","volume":"215","author":"Brummelman","year":"2018","journal-title":"J. Exp. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"8509","DOI":"10.1002\/jcp.27782","article-title":"CD8+ cytotoxic T lymphocytes in cancer immunotherapy: A review","volume":"234","author":"Farhood","year":"2019","journal-title":"J. Cell Physiol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"110331","DOI":"10.1016\/j.celrep.2022.110331","article-title":"PD-1 blockade therapy promotes infiltration of tumor-attacking exhausted T cell clonotypes","volume":"38","author":"Nagasaki","year":"2022","journal-title":"Cell Rep."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e20232104","DOI":"10.1084\/jem.20232104","article-title":"Anti-PD-1 therapy triggers Tfh cell-dependent IL-4 release to boost CD8 T cell responses in tumor-draining lymph nodes","volume":"221","author":"Ruggiu","year":"2024","journal-title":"J. Exp. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"W509","DOI":"10.1093\/nar\/gkaa407","article-title":"TIMER2.0 for analysis of tumor-infiltrating immune cells","volume":"48","author":"Li","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"ref_7","first-page":"100141","article-title":"ClusterProfiler 4.0: A universal enrichment tool for interpreting omics data","volume":"2","author":"Wu","year":"2021","journal-title":"Innovation"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e010057","DOI":"10.1136\/jitc-2024-010057","article-title":"Depletion of tumor-derived CXCL5 improves T cell infiltration and anti-PD-1 therapy response in an obese model of pancreatic cancer","volume":"13","author":"Walsh","year":"2025","journal-title":"J. Immunother. Cancer"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Johnson, D.E., and Cui, Z. (2025). Triggering Pyroptosis in Cancer. Biomolecules, 15.","DOI":"10.3390\/biom15030348"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.chembiol.2024.04.006","article-title":"Metabolism-inflammasome crosstalk shapes innate and adaptive immunity","volume":"31","author":"Wu","year":"2024","journal-title":"Cell Chem Biol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1758834017749748","DOI":"10.1177\/1758834017749748","article-title":"Interferon gamma, an important marker of response to immune checkpoint blockade in non-small cell lung cancer and melanoma patients","volume":"10","author":"Karachaliou","year":"2018","journal-title":"Ther. Adv. Med. Oncol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/s40001-022-00854-1","article-title":"LPCAT1 acts as an independent prognostic biomarker correlated with immune infiltration in hepatocellular carcinoma","volume":"27","author":"Li","year":"2022","journal-title":"Eur. J. Med. Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1007\/s10495-024-02010-y","article-title":"Comprehensive pancancer analysis reveals that LPCAT1 is a novel predictive biomarker for prognosis and immunotherapy response","volume":"29","author":"Gao","year":"2024","journal-title":"Apoptosis"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Kang, I., Theodoropoulos, G., and Wangpaichitr, M. (2025). Targeting the kynurenine pathway: Another therapeutic opportunity in the metabolic crosstalk between cancer and immune cells. Front. Oncol., 14.","DOI":"10.3389\/fonc.2024.1524651"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Gaykema, L.H., van Nieuwland, R.Y., Dekkers, M.C., van Essen, M.F., Heidt, S., Zaldumbide, A., van den Berg, C.W., Rabelink, T.J., and van Kooten, C. (2023). Inhibition of complement activation by CD55 overexpression in human induced pluripotent stem cell derived kidney organoids. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.1058763"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3892\/ol.2023.14187","article-title":"Role of interleukin-32 in cancer progression (Review)","volume":"27","author":"Meng","year":"2023","journal-title":"Oncol. Lett."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1038\/s41591-018-0101-z","article-title":"Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer","volume":"24","author":"Kim","year":"2018","journal-title":"Nat. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1186\/s12967-023-04200-9","article-title":"The role of mitochondria in the resistance of melanoma to PD-1 inhibitors","volume":"21","author":"Du","year":"2023","journal-title":"J. Transl. Med."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Hong, M.M.Y., and Maleki Vareki, S. (2022). Addressing the Elephant in the Immunotherapy Room: Effector T-Cell Priming versus Depletion of Regulatory T-Cells by Anti-CTLA-4 Therapy. Cancers, 14.","DOI":"10.3390\/cancers14061580"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1016\/j.immuni.2022.10.006","article-title":"Regulatory T cells as metabolic sensors","volume":"55","author":"Procaccini","year":"2022","journal-title":"Immunity"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Tomiyama, T., Ueda, Y., Katakai, T., Kondo, N., Okazaki, K., and Kinashi, T. (2013). Antigen-specific suppression and immunological synapse formation by regulatory T cells require the Mst1 kinase. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0073874"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Nair, R., Somasundaram, V., Kuriakose, A., Krishn, S.R., Raben, D., Salazar, R., and Nair, P. (2025). Deciphering T-cell exhaustion in the tumor microenvironment: Paving the way for innovative solid tumor therapies. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1548234"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.ccell.2024.05.013","article-title":"Interruption of the intratumor CD8+ T cell:Treg crosstalk improves the efficacy of PD-1 immunotherapy","volume":"42","author":"Geels","year":"2024","journal-title":"Cancer Cell"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1038\/s41416-022-01939-8","article-title":"Intratumoral PD-1+CD8+ T cells associate poor clinical outcomes and adjuvant chemotherapeutic benefit in gastric cancer","volume":"127","author":"Yu","year":"2022","journal-title":"Br. J. Cancer"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s10120-023-01364-7","article-title":"Clinical relevance of PD-1 positive CD8 T-cells in gastric cancer","volume":"26","author":"Choo","year":"2023","journal-title":"Gastric Cancer"}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/14\/2407\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:13:18Z","timestamp":1760033598000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/14\/2407"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,21]]},"references-count":25,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2025,7]]}},"alternative-id":["cancers17142407"],"URL":"https:\/\/doi.org\/10.3390\/cancers17142407","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,21]]}}}